Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Por um escritor misterioso

Last updated 31 janeiro 2025

Yongkun WEI, Doctor of Medicine, University of Texas MD Anderson Cancer Center, Texas, MD Anderson, Department of Molecular and Cellular Oncology

Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions, Breast Cancer Research

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Saturated fatty acid-induced CSF3 expression via Toll-like receptors.

BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer

The Immunology of Brain Tumors

The tumor-immune ecosystem in shaping metastasis

Why are high EZH2-expressing breast cancer cells prone to bone metastasis?

Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with De Novo Stage IV Breast Cancer

The origin of brain malignancies at the blood–brain barrier

BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer

Recomendado para você